This report aims to provide a comprehensive presentation of the global market for Immuno-oncology Diagnosis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immuno-oncology Diagnosis. This report contains market size and forecasts of Immuno-oncology Diagnosis in global, including the following market information:
Global Immuno-oncology Diagnosis Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Immuno-oncology Diagnosis market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
PCR Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Immuno-oncology Diagnosis include 10x Genomics, Abbott Laboratories, Abcam, Adaptive Biotechnologies, Aethlon Medical, Agena Bioscience, Angle plc, Apocell and ARUP Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immuno-oncology Diagnosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immuno-oncology Diagnosis Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Immuno-oncology Diagnosis Market Segment Percentages, by Type, 2022 (%)
PCR
NGS
Immunoassay
Global Immuno-oncology Diagnosis Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Immuno-oncology Diagnosis Market Segment Percentages, by Application, 2022 (%)
Research
Diagnostics
Global Immuno-oncology Diagnosis Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Immuno-oncology Diagnosis Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immuno-oncology Diagnosis revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immuno-oncology Diagnosis revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
10x Genomics
Abbott Laboratories
Abcam
Adaptive Biotechnologies
Aethlon Medical
Agena Bioscience
Angle plc
Apocell
ARUP Laboratories
Beckman Coulter
Becton Dickinson
Bioarray Genetics
BioCartis
Biocept
Biodesix Inc
BioFluidica
BioGenex 40 bioM?rieux
Bio-Rad
Bio-Techne
Bristol-Myers Squibb
Cancer Genetics
Caris Molecular Diagnostics
CellMax Life
Charles River Laboratories
Chronix Biomedical
Circulogene
Clearbridge BioMedics
Clinical Genomics
Pfizer
Promega
Protagen Diagnostics
Qiagen
Quanterix
Rarecells SAS
Roche Diagnostics
Siemens
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immuno-oncology Diagnosis, market overview.
Chapter 2: Global Immuno-oncology Diagnosis market size in revenue.
Chapter 3: Detailed analysis of Immuno-oncology Diagnosis company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immuno-oncology Diagnosis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Immuno-oncology Diagnosis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immuno-oncology Diagnosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immuno-oncology Diagnosis Overall Market Size
2.1 Global Immuno-oncology Diagnosis Market Size: 2022 VS 2030
2.2 Global Immuno-oncology Diagnosis Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immuno-oncology Diagnosis Players in Global Market
3.2 Top Global Immuno-oncology Diagnosis Companies Ranked by Revenue
3.3 Global Immuno-oncology Diagnosis Revenue by Companies
3.4 Top 3 and Top 5 Immuno-oncology Diagnosis Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immuno-oncology Diagnosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immuno-oncology Diagnosis Players in Global Market
3.6.1 List of Global Tier 1 Immuno-oncology Diagnosis Companies
3.6.2 List of Global Tier 2 and Tier 3 Immuno-oncology Diagnosis Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immuno-oncology Diagnosis Market Size Markets, 2022 & 2030
4.1.2 PCR
4.1.3 NGS
4.1.4 Immunoassay
4.2 By Type - Global Immuno-oncology Diagnosis Revenue & Forecasts
4.2.1 By Type - Global Immuno-oncology Diagnosis Revenue, 2018-2023
4.2.2 By Type - Global Immuno-oncology Diagnosis Revenue, 2024-2030
4.2.3 By Type - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immuno-oncology Diagnosis Market Size, 2022 & 2030
5.1.2 Research
5.1.3 Diagnostics
5.2 By Application - Global Immuno-oncology Diagnosis Revenue & Forecasts
5.2.1 By Application - Global Immuno-oncology Diagnosis Revenue, 2018-2023
5.2.2 By Application - Global Immuno-oncology Diagnosis Revenue, 2024-2030
5.2.3 By Application - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Immuno-oncology Diagnosis Market Size, 2022 & 2030
6.2 By Region - Global Immuno-oncology Diagnosis Revenue & Forecasts
6.2.1 By Region - Global Immuno-oncology Diagnosis Revenue, 2018-2023
6.2.2 By Region - Global Immuno-oncology Diagnosis Revenue, 2024-2030
6.2.3 By Region - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Immuno-oncology Diagnosis Revenue, 2018-2030
6.3.2 US Immuno-oncology Diagnosis Market Size, 2018-2030
6.3.3 Canada Immuno-oncology Diagnosis Market Size, 2018-2030
6.3.4 Mexico Immuno-oncology Diagnosis Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Immuno-oncology Diagnosis Revenue, 2018-2030
6.4.2 Germany Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.3 France Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.4 U.K. Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.5 Italy Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.6 Russia Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.7 Nordic Countries Immuno-oncology Diagnosis Market Size, 2018-2030
6.4.8 Benelux Immuno-oncology Diagnosis Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Immuno-oncology Diagnosis Revenue, 2018-2030
6.5.2 China Immuno-oncology Diagnosis Market Size, 2018-2030
6.5.3 Japan Immuno-oncology Diagnosis Market Size, 2018-2030
6.5.4 South Korea Immuno-oncology Diagnosis Market Size, 2018-2030
6.5.5 Southeast Asia Immuno-oncology Diagnosis Market Size, 2018-2030
6.5.6 India Immuno-oncology Diagnosis Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Immuno-oncology Diagnosis Revenue, 2018-2030
6.6.2 Brazil Immuno-oncology Diagnosis Market Size, 2018-2030
6.6.3 Argentina Immuno-oncology Diagnosis Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immuno-oncology Diagnosis Revenue, 2018-2030
6.7.2 Turkey Immuno-oncology Diagnosis Market Size, 2018-2030
6.7.3 Israel Immuno-oncology Diagnosis Market Size, 2018-2030
6.7.4 Saudi Arabia Immuno-oncology Diagnosis Market Size, 2018-2030
6.7.5 UAE Immuno-oncology Diagnosis Market Size, 2018-2030
7 Immuno-oncology Diagnosis Companies Profiles
7.1 10x Genomics
7.1.1 10x Genomics Company Summary
7.1.2 10x Genomics Business Overview
7.1.3 10x Genomics Immuno-oncology Diagnosis Major Product Offerings
7.1.4 10x Genomics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.1.5 10x Genomics Key News & Latest Developments
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Summary
7.2.2 Abbott Laboratories Business Overview
7.2.3 Abbott Laboratories Immuno-oncology Diagnosis Major Product Offerings
7.2.4 Abbott Laboratories Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.2.5 Abbott Laboratories Key News & Latest Developments
7.3 Abcam
7.3.1 Abcam Company Summary
7.3.2 Abcam Business Overview
7.3.3 Abcam Immuno-oncology Diagnosis Major Product Offerings
7.3.4 Abcam Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.3.5 Abcam Key News & Latest Developments
7.4 Adaptive Biotechnologies
7.4.1 Adaptive Biotechnologies Company Summary
7.4.2 Adaptive Biotechnologies Business Overview
7.4.3 Adaptive Biotechnologies Immuno-oncology Diagnosis Major Product Offerings
7.4.4 Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.4.5 Adaptive Biotechnologies Key News & Latest Developments
7.5 Aethlon Medical
7.5.1 Aethlon Medical Company Summary
7.5.2 Aethlon Medical Business Overview
7.5.3 Aethlon Medical Immuno-oncology Diagnosis Major Product Offerings
7.5.4 Aethlon Medical Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.5.5 Aethlon Medical Key News & Latest Developments
7.6 Agena Bioscience
7.6.1 Agena Bioscience Company Summary
7.6.2 Agena Bioscience Business Overview
7.6.3 Agena Bioscience Immuno-oncology Diagnosis Major Product Offerings
7.6.4 Agena Bioscience Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.6.5 Agena Bioscience Key News & Latest Developments
7.7 Angle plc
7.7.1 Angle plc Company Summary
7.7.2 Angle plc Business Overview
7.7.3 Angle plc Immuno-oncology Diagnosis Major Product Offerings
7.7.4 Angle plc Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.7.5 Angle plc Key News & Latest Developments
7.8 Apocell
7.8.1 Apocell Company Summary
7.8.2 Apocell Business Overview
7.8.3 Apocell Immuno-oncology Diagnosis Major Product Offerings
7.8.4 Apocell Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.8.5 Apocell Key News & Latest Developments
7.9 ARUP Laboratories
7.9.1 ARUP Laboratories Company Summary
7.9.2 ARUP Laboratories Business Overview
7.9.3 ARUP Laboratories Immuno-oncology Diagnosis Major Product Offerings
7.9.4 ARUP Laboratories Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.9.5 ARUP Laboratories Key News & Latest Developments
7.10 Beckman Coulter
7.10.1 Beckman Coulter Company Summary
7.10.2 Beckman Coulter Business Overview
7.10.3 Beckman Coulter Immuno-oncology Diagnosis Major Product Offerings
7.10.4 Beckman Coulter Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.10.5 Beckman Coulter Key News & Latest Developments
7.11 Becton Dickinson
7.11.1 Becton Dickinson Company Summary
7.11.2 Becton Dickinson Business Overview
7.11.3 Becton Dickinson Immuno-oncology Diagnosis Major Product Offerings
7.11.4 Becton Dickinson Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.11.5 Becton Dickinson Key News & Latest Developments
7.12 Bioarray Genetics
7.12.1 Bioarray Genetics Company Summary
7.12.2 Bioarray Genetics Business Overview
7.12.3 Bioarray Genetics Immuno-oncology Diagnosis Major Product Offerings
7.12.4 Bioarray Genetics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.12.5 Bioarray Genetics Key News & Latest Developments
7.13 BioCartis
7.13.1 BioCartis Company Summary
7.13.2 BioCartis Business Overview
7.13.3 BioCartis Immuno-oncology Diagnosis Major Product Offerings
7.13.4 BioCartis Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.13.5 BioCartis Key News & Latest Developments
7.14 Biocept
7.14.1 Biocept Company Summary
7.14.2 Biocept Business Overview
7.14.3 Biocept Immuno-oncology Diagnosis Major Product Offerings
7.14.4 Biocept Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.14.5 Biocept Key News & Latest Developments
7.15 Biodesix Inc
7.15.1 Biodesix Inc Company Summary
7.15.2 Biodesix Inc Business Overview
7.15.3 Biodesix Inc Immuno-oncology Diagnosis Major Product Offerings
7.15.4 Biodesix Inc Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.15.5 Biodesix Inc Key News & Latest Developments
7.16 BioFluidica
7.16.1 BioFluidica Company Summary
7.16.2 BioFluidica Business Overview
7.16.3 BioFluidica Immuno-oncology Diagnosis Major Product Offerings
7.16.4 BioFluidica Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.16.5 BioFluidica Key News & Latest Developments
7.17 BioGenex 40 bioM?rieux
7.17.1 BioGenex 40 bioM?rieux Company Summary
7.17.2 BioGenex 40 bioM?rieux Business Overview
7.17.3 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Major Product Offerings
7.17.4 BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.17.5 BioGenex 40 bioM?rieux Key News & Latest Developments
7.18 Bio-Rad
7.18.1 Bio-Rad Company Summary
7.18.2 Bio-Rad Business Overview
7.18.3 Bio-Rad Immuno-oncology Diagnosis Major Product Offerings
7.18.4 Bio-Rad Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.18.5 Bio-Rad Key News & Latest Developments
7.19 Bio-Techne
7.19.1 Bio-Techne Company Summary
7.19.2 Bio-Techne Business Overview
7.19.3 Bio-Techne Immuno-oncology Diagnosis Major Product Offerings
7.19.4 Bio-Techne Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.19.5 Bio-Techne Key News & Latest Developments
7.20 Bristol-Myers Squibb
7.20.1 Bristol-Myers Squibb Company Summary
7.20.2 Bristol-Myers Squibb Business Overview
7.20.3 Bristol-Myers Squibb Immuno-oncology Diagnosis Major Product Offerings
7.20.4 Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.20.5 Bristol-Myers Squibb Key News & Latest Developments
7.21 Cancer Genetics
7.21.1 Cancer Genetics Company Summary
7.21.2 Cancer Genetics Business Overview
7.21.3 Cancer Genetics Immuno-oncology Diagnosis Major Product Offerings
7.21.4 Cancer Genetics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.21.5 Cancer Genetics Key News & Latest Developments
7.22 Caris Molecular Diagnostics
7.22.1 Caris Molecular Diagnostics Company Summary
7.22.2 Caris Molecular Diagnostics Business Overview
7.22.3 Caris Molecular Diagnostics Immuno-oncology Diagnosis Major Product Offerings
7.22.4 Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.22.5 Caris Molecular Diagnostics Key News & Latest Developments
7.23 CellMax Life
7.23.1 CellMax Life Company Summary
7.23.2 CellMax Life Business Overview
7.23.3 CellMax Life Immuno-oncology Diagnosis Major Product Offerings
7.23.4 CellMax Life Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.23.5 CellMax Life Key News & Latest Developments
7.24 Charles River Laboratories
7.24.1 Charles River Laboratories Company Summary
7.24.2 Charles River Laboratories Business Overview
7.24.3 Charles River Laboratories Immuno-oncology Diagnosis Major Product Offerings
7.24.4 Charles River Laboratories Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.24.5 Charles River Laboratories Key News & Latest Developments
7.25 Chronix Biomedical
7.25.1 Chronix Biomedical Company Summary
7.25.2 Chronix Biomedical Business Overview
7.25.3 Chronix Biomedical Immuno-oncology Diagnosis Major Product Offerings
7.25.4 Chronix Biomedical Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.25.5 Chronix Biomedical Key News & Latest Developments
7.26 Circulogene
7.26.1 Circulogene Company Summary
7.26.2 Circulogene Business Overview
7.26.3 Circulogene Immuno-oncology Diagnosis Major Product Offerings
7.26.4 Circulogene Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.26.5 Circulogene Key News & Latest Developments
7.27 Clearbridge BioMedics
7.27.1 Clearbridge BioMedics Company Summary
7.27.2 Clearbridge BioMedics Business Overview
7.27.3 Clearbridge BioMedics Immuno-oncology Diagnosis Major Product Offerings
7.27.4 Clearbridge BioMedics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.27.5 Clearbridge BioMedics Key News & Latest Developments
7.28 Clinical Genomics
7.28.1 Clinical Genomics Company Summary
7.28.2 Clinical Genomics Business Overview
7.28.3 Clinical Genomics Immuno-oncology Diagnosis Major Product Offerings
7.28.4 Clinical Genomics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.28.5 Clinical Genomics Key News & Latest Developments
7.29 Pfizer
7.29.1 Pfizer Company Summary
7.29.2 Pfizer Business Overview
7.29.3 Pfizer Immuno-oncology Diagnosis Major Product Offerings
7.29.4 Pfizer Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.29.5 Pfizer Key News & Latest Developments
7.30 Promega
7.30.1 Promega Company Summary
7.30.2 Promega Business Overview
7.30.3 Promega Immuno-oncology Diagnosis Major Product Offerings
7.30.4 Promega Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.30.5 Promega Key News & Latest Developments
7.31 Protagen Diagnostics
7.31.1 Protagen Diagnostics Company Summary
7.31.2 Protagen Diagnostics Business Overview
7.31.3 Protagen Diagnostics Immuno-oncology Diagnosis Major Product Offerings
7.31.4 Protagen Diagnostics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.31.5 Protagen Diagnostics Key News & Latest Developments
7.32 Qiagen
7.32.1 Qiagen Company Summary
7.32.2 Qiagen Business Overview
7.32.3 Qiagen Immuno-oncology Diagnosis Major Product Offerings
7.32.4 Qiagen Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.32.5 Qiagen Key News & Latest Developments
7.33 Quanterix
7.33.1 Quanterix Company Summary
7.33.2 Quanterix Business Overview
7.33.3 Quanterix Immuno-oncology Diagnosis Major Product Offerings
7.33.4 Quanterix Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.33.5 Quanterix Key News & Latest Developments
7.34 Rarecells SAS
7.34.1 Rarecells SAS Company Summary
7.34.2 Rarecells SAS Business Overview
7.34.3 Rarecells SAS Immuno-oncology Diagnosis Major Product Offerings
7.34.4 Rarecells SAS Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.34.5 Rarecells SAS Key News & Latest Developments
7.35 Roche Diagnostics
7.35.1 Roche Diagnostics Company Summary
7.35.2 Roche Diagnostics Business Overview
7.35.3 Roche Diagnostics Immuno-oncology Diagnosis Major Product Offerings
7.35.4 Roche Diagnostics Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.35.5 Roche Diagnostics Key News & Latest Developments
7.36 Siemens
7.36.1 Siemens Company Summary
7.36.2 Siemens Business Overview
7.36.3 Siemens Immuno-oncology Diagnosis Major Product Offerings
7.36.4 Siemens Immuno-oncology Diagnosis Revenue in Global Market (2018-2023)
7.36.5 Siemens Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Immuno-oncology Diagnosis Market Opportunities & Trends in Global Market
Table 2. Immuno-oncology Diagnosis Market Drivers in Global Market
Table 3. Immuno-oncology Diagnosis Market Restraints in Global Market
Table 4. Key Players of Immuno-oncology Diagnosis in Global Market
Table 5. Top Immuno-oncology Diagnosis Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Immuno-oncology Diagnosis Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Immuno-oncology Diagnosis Revenue Share by Companies, 2018-2023
Table 8. Global Companies Immuno-oncology Diagnosis Product Type
Table 9. List of Global Tier 1 Immuno-oncology Diagnosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immuno-oncology Diagnosis Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Immuno-oncology Diagnosis Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Immuno-oncology Diagnosis Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Immuno-oncology Diagnosis Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Immuno-oncology Diagnosis Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Immuno-oncology Diagnosis Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Immuno-oncology Diagnosis Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Immuno-oncology Diagnosis Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Immuno-oncology Diagnosis Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Immuno-oncology Diagnosis Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Immuno-oncology Diagnosis Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Immuno-oncology Diagnosis Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Immuno-oncology Diagnosis Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Immuno-oncology Diagnosis Revenue, (US$, Mn), 2024-2030
Table 30. 10x Genomics Company Summary
Table 31. 10x Genomics Immuno-oncology Diagnosis Product Offerings
Table 32. 10x Genomics Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 33. 10x Genomics Key News & Latest Developments
Table 34. Abbott Laboratories Company Summary
Table 35. Abbott Laboratories Immuno-oncology Diagnosis Product Offerings
Table 36. Abbott Laboratories Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 37. Abbott Laboratories Key News & Latest Developments
Table 38. Abcam Company Summary
Table 39. Abcam Immuno-oncology Diagnosis Product Offerings
Table 40. Abcam Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 41. Abcam Key News & Latest Developments
Table 42. Adaptive Biotechnologies Company Summary
Table 43. Adaptive Biotechnologies Immuno-oncology Diagnosis Product Offerings
Table 44. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 45. Adaptive Biotechnologies Key News & Latest Developments
Table 46. Aethlon Medical Company Summary
Table 47. Aethlon Medical Immuno-oncology Diagnosis Product Offerings
Table 48. Aethlon Medical Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 49. Aethlon Medical Key News & Latest Developments
Table 50. Agena Bioscience Company Summary
Table 51. Agena Bioscience Immuno-oncology Diagnosis Product Offerings
Table 52. Agena Bioscience Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 53. Agena Bioscience Key News & Latest Developments
Table 54. Angle plc Company Summary
Table 55. Angle plc Immuno-oncology Diagnosis Product Offerings
Table 56. Angle plc Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 57. Angle plc Key News & Latest Developments
Table 58. Apocell Company Summary
Table 59. Apocell Immuno-oncology Diagnosis Product Offerings
Table 60. Apocell Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 61. Apocell Key News & Latest Developments
Table 62. ARUP Laboratories Company Summary
Table 63. ARUP Laboratories Immuno-oncology Diagnosis Product Offerings
Table 64. ARUP Laboratories Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 65. ARUP Laboratories Key News & Latest Developments
Table 66. Beckman Coulter Company Summary
Table 67. Beckman Coulter Immuno-oncology Diagnosis Product Offerings
Table 68. Beckman Coulter Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 69. Beckman Coulter Key News & Latest Developments
Table 70. Becton Dickinson Company Summary
Table 71. Becton Dickinson Immuno-oncology Diagnosis Product Offerings
Table 72. Becton Dickinson Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 73. Becton Dickinson Key News & Latest Developments
Table 74. Bioarray Genetics Company Summary
Table 75. Bioarray Genetics Immuno-oncology Diagnosis Product Offerings
Table 76. Bioarray Genetics Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 77. Bioarray Genetics Key News & Latest Developments
Table 78. BioCartis Company Summary
Table 79. BioCartis Immuno-oncology Diagnosis Product Offerings
Table 80. BioCartis Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 81. BioCartis Key News & Latest Developments
Table 82. Biocept Company Summary
Table 83. Biocept Immuno-oncology Diagnosis Product Offerings
Table 84. Biocept Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 85. Biocept Key News & Latest Developments
Table 86. Biodesix Inc Company Summary
Table 87. Biodesix Inc Immuno-oncology Diagnosis Product Offerings
Table 88. Biodesix Inc Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 89. Biodesix Inc Key News & Latest Developments
Table 90. BioFluidica Company Summary
Table 91. BioFluidica Immuno-oncology Diagnosis Product Offerings
Table 92. BioFluidica Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 93. BioFluidica Key News & Latest Developments
Table 94. BioGenex 40 bioM?rieux Company Summary
Table 95. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Product Offerings
Table 96. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 97. BioGenex 40 bioM?rieux Key News & Latest Developments
Table 98. Bio-Rad Company Summary
Table 99. Bio-Rad Immuno-oncology Diagnosis Product Offerings
Table 100. Bio-Rad Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 101. Bio-Rad Key News & Latest Developments
Table 102. Bio-Techne Company Summary
Table 103. Bio-Techne Immuno-oncology Diagnosis Product Offerings
Table 104. Bio-Techne Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 105. Bio-Techne Key News & Latest Developments
Table 106. Bristol-Myers Squibb Company Summary
Table 107. Bristol-Myers Squibb Immuno-oncology Diagnosis Product Offerings
Table 108. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 109. Bristol-Myers Squibb Key News & Latest Developments
Table 110. Cancer Genetics Company Summary
Table 111. Cancer Genetics Immuno-oncology Diagnosis Product Offerings
Table 112. Cancer Genetics Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 113. Cancer Genetics Key News & Latest Developments
Table 114. Caris Molecular Diagnostics Company Summary
Table 115. Caris Molecular Diagnostics Immuno-oncology Diagnosis Product Offerings
Table 116. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 117. Caris Molecular Diagnostics Key News & Latest Developments
Table 118. CellMax Life Company Summary
Table 119. CellMax Life Immuno-oncology Diagnosis Product Offerings
Table 120. CellMax Life Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 121. CellMax Life Key News & Latest Developments
Table 122. Charles River Laboratories Company Summary
Table 123. Charles River Laboratories Immuno-oncology Diagnosis Product Offerings
Table 124. Charles River Laboratories Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 125. Charles River Laboratories Key News & Latest Developments
Table 126. Chronix Biomedical Company Summary
Table 127. Chronix Biomedical Immuno-oncology Diagnosis Product Offerings
Table 128. Chronix Biomedical Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 129. Chronix Biomedical Key News & Latest Developments
Table 130. Circulogene Company Summary
Table 131. Circulogene Immuno-oncology Diagnosis Product Offerings
Table 132. Circulogene Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 133. Circulogene Key News & Latest Developments
Table 134. Clearbridge BioMedics Company Summary
Table 135. Clearbridge BioMedics Immuno-oncology Diagnosis Product Offerings
Table 136. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 137. Clearbridge BioMedics Key News & Latest Developments
Table 138. Clinical Genomics Company Summary
Table 139. Clinical Genomics Immuno-oncology Diagnosis Product Offerings
Table 140. Clinical Genomics Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 141. Clinical Genomics Key News & Latest Developments
Table 142. Pfizer Company Summary
Table 143. Pfizer Immuno-oncology Diagnosis Product Offerings
Table 144. Pfizer Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 145. Pfizer Key News & Latest Developments
Table 146. Promega Company Summary
Table 147. Promega Immuno-oncology Diagnosis Product Offerings
Table 148. Promega Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 149. Promega Key News & Latest Developments
Table 150. Protagen Diagnostics Company Summary
Table 151. Protagen Diagnostics Immuno-oncology Diagnosis Product Offerings
Table 152. Protagen Diagnostics Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 153. Protagen Diagnostics Key News & Latest Developments
Table 154. Qiagen Company Summary
Table 155. Qiagen Immuno-oncology Diagnosis Product Offerings
Table 156. Qiagen Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 157. Qiagen Key News & Latest Developments
Table 158. Quanterix Company Summary
Table 159. Quanterix Immuno-oncology Diagnosis Product Offerings
Table 160. Quanterix Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 161. Quanterix Key News & Latest Developments
Table 162. Rarecells SAS Company Summary
Table 163. Rarecells SAS Immuno-oncology Diagnosis Product Offerings
Table 164. Rarecells SAS Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 165. Rarecells SAS Key News & Latest Developments
Table 166. Roche Diagnostics Company Summary
Table 167. Roche Diagnostics Immuno-oncology Diagnosis Product Offerings
Table 168. Roche Diagnostics Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 169. Roche Diagnostics Key News & Latest Developments
Table 170. Siemens Company Summary
Table 171. Siemens Immuno-oncology Diagnosis Product Offerings
Table 172. Siemens Immuno-oncology Diagnosis Revenue (US$, Mn) & (2018-2023)
Table 173. Siemens Key News & Latest Developments
List of Figures
Figure 1. Immuno-oncology Diagnosis Segment by Type in 2022
Figure 2. Immuno-oncology Diagnosis Segment by Application in 2022
Figure 3. Global Immuno-oncology Diagnosis Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immuno-oncology Diagnosis Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Immuno-oncology Diagnosis Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immuno-oncology Diagnosis Revenue in 2022
Figure 8. By Type - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 9. By Application - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 10. By Type - Global Immuno-oncology Diagnosis Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 12. By Application - Global Immuno-oncology Diagnosis Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 14. By Region - Global Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 15. By Country - North America Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 16. US Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 20. Germany Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 21. France Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 28. China Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 32. India Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 34. Brazil Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Immuno-oncology Diagnosis Revenue Market Share, 2018-2030
Figure 37. Turkey Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Immuno-oncology Diagnosis Revenue, (US$, Mn), 2018-2030
Figure 41. 10x Genomics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Abbott Laboratories Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abcam Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Adaptive Biotechnologies Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Aethlon Medical Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Agena Bioscience Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Angle plc Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Apocell Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. ARUP Laboratories Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Beckman Coulter Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Becton Dickinson Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bioarray Genetics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. BioCartis Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Biocept Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Biodesix Inc Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. BioFluidica Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. BioGenex 40 bioM?rieux Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Bio-Rad Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Bio-Techne Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Bristol-Myers Squibb Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Cancer Genetics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Caris Molecular Diagnostics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. CellMax Life Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Charles River Laboratories Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Chronix Biomedical Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Circulogene Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 67. Clearbridge BioMedics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 68. Clinical Genomics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 69. Pfizer Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 70. Promega Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 71. Protagen Diagnostics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 72. Qiagen Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 73. Quanterix Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 74. Rarecells SAS Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 75. Roche Diagnostics Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 76. Siemens Immuno-oncology Diagnosis Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
